NCT02709928View on ClinicalTrials.gov

Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Healthy Adults, Elderly Subjects
Interventions
DRUG

TD-0714

DRUG

Placebo

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY

NCT02709928 - Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects | Biotech Hunter | Biotech Hunter